Adherence to Treatment with Oral Nucleoside/Nucleotide Analogs in Patients with Chronic Hepatitis B
暂无分享,去创建一个
[1] Y. Altuntas,et al. Determining INR Awareness of the Patients who Use Warfarin and Rates of Achieving the Target Dosage , 2020, Sisli Etfal Hastanesi tip bulteni.
[2] B. McMahon,et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.
[3] P. Farazi,et al. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B , 2018, Global health action.
[4] Yunus Gürbüz,et al. Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B , 2017, Balkan medical journal.
[5] B. Cowie,et al. Factors associated with poor adherence to antiviral treatment for hepatitis B , 2017, Journal of viral hepatitis.
[6] F. Tabak,et al. Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group. , 2017, AIDS research and human retroviruses.
[7] U. Akarca,et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[8] P. Siersema,et al. Real life adherence of chronic hepatitis B patients to entecavir treatment. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[9] Tao Yu,et al. Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study , 2015, Patient preference and adherence.
[10] Mayank Jain,et al. Adherence to oral antivirals in patients with chronic hepatitis B infection , 2014, Indian Journal of Gastroenterology.
[11] R. Fontana,et al. Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs , 2012, Journal of viral hepatitis.
[12] C. Selinger,et al. Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires. , 2012, World journal of hepatology.
[13] S. Pol,et al. The Role of Adherence in Virological Suppression in Patients Receiving Anti-HBV Analogues , 2012, Antiviral therapy.
[14] A. Lok,et al. Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. , 2011, Journal of hepatology.
[15] J. Stockman,et al. Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B , 2010 .
[16] J. Feld,et al. Endpoints of therapy in chronic hepatitis B , 2009, Hepatology.
[17] A. Cross,et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. , 2006, The New England journal of medicine.
[18] R. Hays,et al. A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors , 2001, Annals of Internal Medicine.